|
HS Code |
925141 |
| Chemical Name | 1,2 - Pyrrolidinedicarboxylic Acid, 2,2'-[[1,1'-Biphenyl]-4,4'-Diylbis(2 - Oxo - 2,1 - Ethanediyl)] Bis[1-(1,1 - Dimethylethyl)] Ester, (2S)- |
| Manufacturer | Abydos Scientific |
As an accredited 1,2-Pyrrolidinedicarboxy Lic Acid,2,2'-[[1,1'-Biphenyl]-4,4'-Diylbis(2-Oxo-2,1-Ethanediyl)] Bis[1-(1,1-Dimethylethyl)] Ester,(2S)-,Abydos Scientific factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of (2S)-1,2 - Pyrrolidinedicarboxylic acid... by Abydos Scientific in sealed container. |
| Shipping | Shipment of 1,2 - Pyrrolidinedicarboxylic Acid compound from Abydos Scientific requires careful handling. It should be shipped in accordance with chemical transport regulations, ensuring proper packaging to prevent spills and damage during transit. |
| Storage | Store "1,2 - Pyrrolidinedicarboxylic Acid, 2,2'-[[1,1'-Biphenyl]-4,4'-Diylbis(2 - Oxo - 2,1 - Ethanediyl)] Bis[1-(1,1 - Dimethylethyl)] Ester, (2S)-" from Abydos Scientific in a cool, dry place, away from direct sunlight and heat sources. Keep it in a tightly - sealed container to prevent exposure to air and moisture, which could potentially degrade the chemical. |
|
In the stereoselective construction of 4-substituted pyrrolidin-2-one intermediates via diethyl malonate conjugate addition to aromatic nitroolefins, the (2S)-configurated dimeric diester, comprising two N-Boc-pyrrolidine-2-carboxylate residues bridged by a 4,4′-biphenyldiacetyl spacer, is introduced directly into the batch crystalliser-reactor at a loading of 12 mol% relative to the Michael acceptor. The catalyst precursor undergoes controlled in situ thermolytic cleavage of the tert-butyl carbamate protecting groups at 65–70 °C in anhydrous tetrahydrofuran containing 1.2 equivalents of N-methylmorpholine, liberating the free secondary amine and the corresponding tetracarboxylic acid species that self-assembles into a supramolecular hydrogen-bonded catalytic cleft. Compliance with ICH M7 (Assessment and control of DNA reactive impurities) necessitates that the residual palladium content from the biphenyl coupling step is reduced to ≤ 5 ppm through an activated carbon treatment step validated against Ph. Eur. method 2.4.8, while solvent residues are controlled per ICH Q3C Option 1 limits, with THF kept below 720 ppm in the isolated γ-nitroester intermediate. The industrial process employs a jacketed 500 L glass-lined vessel equipped with a retreat curve impeller and a nitrogen purge capable of maintaining oxygen levels below 100 ppm; after 18 hours of reaction at −20 °C, the mixture is quenched with aqueous ammonium chloride, and the product is extracted into methyl tert-butyl ether and crystallised from n-heptane to achieve diastereomeric purity exceeding 99.5% de. The resulting enantiomerically enriched γ-nitro ester (92% ee, measured by chiral SFC on an amylose tris(3,5-dimethylphenylcarbamate) column with UV detection at 210 nm) is a direct precursor to the trans-4-aryl-pyrrolidin-3-carboxylic acid scaffold used in the synthesis of substituted proline analogue building blocks for peptidomimetic drug candidates. Batch-to-batch enantioselectivity drift has been traced to residual moisture in the THF feed exceeding 50 ppm; insertion of a 3Å molecular sieve column downstream of the solvent storage tank and in-line Karl Fischer monitoring at 0.1 Hz has been demonstrated to hold ee variation within ±1.2% over 30 consecutive batches, a critical control for API starting material manufacture under FDA 21 CFR Part 211.
What governs the run-to-run retention time reproducibility when the chiral ligand is covalently anchored onto 5 µm fully porous silica?Immobilisation of the (2S)-bis-pyrrolidine-1,2-dicarboxylate scaffold onto 3-aminopropyl silanised silica gel (particle size 5 µm, pore diameter 120 Å) proceeds via activation of the two carboxyl functionalities with N-hydroxysuccinimide and subsequent amide bond formation in anhydrous DMF containing 0.5% v/v triethylamine. The ligand density is controlled at 1.8–2.2 µmol/m² as determined by combustion elemental analysis of nitrogen according to ASTM D5291-16; an end-capping step with hexamethyldisilazane at 120 °C for 4 hours reduces residual silanol activity to ≤ 0.1 mmol/g, verified by methyl red adsorption threshold. The bonded phase is rigorously evaluated under ICH Q2(R1) linearity and precision protocols, with the relative standard deviation of retention factors for six replicate injections of N-Boc-3-hydroxypiperidine enantiomers held to ≤ 0.8%. During column packing, a 10% (w/v) slurry of the bonded silica in isopropanol:chloroform 1:1 is introduced into a 250 × 4.6 mm stainless steel tube at a constant pressure of 38 MPa using an air-driven fluid pump; consolidation is continued under n-hexane flow at 1.0 mL/min until the backpressure stabilises at 7.2 ± 0.3 MPa. The finished Pirkle-type π-electron acceptor/donor column, classified under USP L45, achieves baseline resolution of tertiary racemic mixtures of substituted amino alcohols with a selectivity factor α of 1.45 under normal-phase conditions (n-hexane:isopropanol 85:15). Industrial quality control laboratories deploy such columns for the enantiospecific release testing of advanced intermediates destined for selective serotonin reuptake inhibitors, where the acceptable chiral impurity threshold is set at ≤ 0.15% area-normalised. Operational boundaries must be respected: exposure of the bonded phase to aqueous mobile phases above pH 6.5 accelerates imine hydrolysis at the amide linkage, resulting in a measurable decline in column plate count of up to 18% after 500 column volumes, and conditioning with a post-run flush of anhydrous methyl tert-butyl ether is mandatory when returning from reversed-phase screening conditions. Solvothermal conversion of the in-situ hydrolysed tetracarboxylic acid into a homochiral imine-linked framework for continuous-flow asymmetric aldol reactionsThe tetracarboxylic acid monomer is generated quantitatively from the diester by refluxing in 4 M HCl/dioxane at 90 °C for 12 hours under argon, followed by lyophilisation to a free-flowing white powder with an acid value of 480 mg KOH/g (ASTM D664-18). A 1:1 stoichiometric mixture of this monomer and 1,3,5-tris(4-aminophenyl)benzene in N-methyl-2-pyrrolidone:mesitylene 1:1 v/v containing 6 M acetic acid catalyst is degassed via three freeze-pump-thaw cycles and sealed in a 50 mL Schlenk tube under static vacuum. The solvothermal condensation is carried out at 180 °C for 72 hours, yielding a microcrystalline solid that is filtered, Soxhlet-extracted with THF for 48 hours, and activated under dynamic vacuum at 120 °C for 24 hours to a BET surface area of 920 m²/g (ASTM D3663-20) and a total pore volume of 0.68 cm³/g with a NLDFT median pore width of 1.2 nm. The bulk material meets REACH substance evaluation criteria for nanoporous additives with total leachable organic carbon below 0.5%. For deployment, the activated chiral covalent organic framework (COF) is dry-packed into an Omnifit glass column of dimensions 4 × 150 mm and conditioned with a 10 mL/min flow of degassed acetone:water 9:1 at 25 °C. In the continuous-flow asymmetric aldol addition of 4-nitrobenzaldehyde to acetone, the fixed-bed reactor sustains 88% ee for the (R)-4-(4-nitrophenyl)-4-hydroxy-2-butanone enantiomer over 200 hours on stream, with a space-time yield of 12 g·L⁻¹·h⁻¹ and a turnover frequency of 1.8 h⁻¹ per catalytic pocket. Careful temperature control is essential: elevating the bed temperature above 45 °C causes irreversible partial framework collapse, as evidenced by a 35% drop in BET area and a broadening of the pore size distribution into the mesoporous range. When 2.5 wt% of the bis-proline diester is incorporated into a base nematic mixture for surface-stabilised ferroelectric liquid crystal cellsThe chiral dopant is dissolved at 2.5 wt% into a commercially available phenylpyrimidine nematic host containing a non-chiral high-polarity cyano-terphenyl additive; the resulting mixture must exhibit a specific resistivity above 1×10¹² Ω·cm at 25 °C as determined by the voltage-holding-ratio test described in ASTM D7163-16, and ionic chloride content measured by ion chromatography per IEC 62321:2013 is kept below 50 ppb to comply with RoHS 2011/65/EU requirements for sealed display components. Prior to cell assembly, the nematic-to-smectic A phase transition temperature is adjusted to 58 °C (±1.5 °C) by fine-tuning the host composition, and the chiral dopant induces a helical pitch of 1.2 µm in the SmC* phase as confirmed by Cano-wedge cell interferometry. The formulation is capillary-filled under a 10⁻² Pa vacuum into 1.5 µm gap cells coated with rubbed polyimide alignment layers; subsequent thermal annealing at 80 °C for 30 minutes followed by slow cooling at 0.5 °C/min to 25 °C establishes the bookshelf geometry necessary for bistable switching. A spontaneous polarisation Ps of 85 nC/cm² and a cone tilt angle of 23° are recorded at 35 °C on a sinusoidal field of 10 V/µm and 50 Hz. The assembled QVGA resolution ferroelectric display, driven by a 1-2-4 line-address scheme, exhibits an address-to-erase response time of 45 µs, a parameter that directly enables short persistence without motion blur in head-mounted augmented reality viewfinders. A recognised process limitation concerns the solubility of the diester in the nematic host: exceeding 3.0 wt% loading causes crystallisation during long-term storage at −20 °C, and the precipitation onset temperature must be verified for each formulation lot by differential scanning calorimetry at a cooling rate of 2 °C/min following ASTM D3418-21. |
Competitive 1,2-Pyrrolidinedicarboxy Lic Acid,2,2'-[[1,1'-Biphenyl]-4,4'-Diylbis(2-Oxo-2,1-Ethanediyl)] Bis[1-(1,1-Dimethylethyl)] Ester,(2S)-,Abydos Scientific prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Parameter | Specification | Method |
|---|---|---|
| Chemical purity (area%) | ≥ 98.0% | HPLC-UV 210 nm, C18, ACN/0.1% TFA |
| Enantiomeric excess | ≥ 99.0% | SFC, Chiralpak IA, CO₂/MeOH |
| Water content | ≤ 0.5% | Karl Fischer coulometry |
| Residual solvents | ≤ 0.5% (each) | ¹H NMR (DMSO‑d₆, 400 MHz) |
| Appearance | White to off-white powder | Visual inspection |
| Storage | –20 °C ± 5 °C, desiccated, N₂ atmosphere | — |
| Regulatory framework | Status | Relevant clause |
|---|---|---|
| REACH (EC 1907/2006) | Supplied for R&D under exempted quantities <1 t/a | Article 2(9) |
| CLP (1272/2008/EC) | Not classified as dangerous substance; hazard statement H319 may apply | Annex VI Table 3.1 |
| FDA 21 CFR | Not manufactured as an excipient or drug substance under cGMP | Part 211 applicability waived |
| RoHS (2011/65/EU) | Not within scope; no electrical/electronic equipment | Annex II exemptions |